Symbols

DMIIU

Drugs America-U·NASDAQ

--(--)

6.96 / 10

Outperform

Capital flow analysis registers 6.96/10, pointing to robust liquidity with positive inflow trends across most scales. The slight negative tilt in block and large-size flows warrants monitoring, but overall fund dynamics reinforce the positive technical and fundamental signals.

Fund Flow Rating

What is the market sentiment for DMIIU?

DMIIU holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 6.96/10 (Outperform).